Acute kidney injury associated with immune checkpoint inhibitors: A pharmacovigilance study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Acute kidney injury associated with immune checkpoint inhibitors: A pharmacovigilance study

Published:2022-12 Issue: Volume:113 Page:109350
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Zhu Jianhong,Wu Jialing,Chen Pengwei,You Kaiyun,Su Jianan,Gao Ziqing,Bi Zhuofei,Feng Min

Funder

National Natural Science Foundation of China

Guangzhou Science and Technology Program key projects

Traditional Chinese Medicine Bureau of Guangdong Province

Science and Technology Planning Project of Guangdong Province

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference30 articles.

1. A decade of immune-checkpoint inhibitors in cancer therapy;Robert;Nat. Commun.,2020

2. Renal Complications Related to Checkpoint Inhibitors: Diagnostic and Therapeutic Strategies;Belliere;Diagnostics (Basel),2021

3. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance;Martins;Nat. Rev. Clin. Oncol.,2019

4. Moving towards personalized treatments of immune-related adverse events;Esfahani;Nat. Rev. Clin. Oncol.,2020

5. The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors;Seethapathy;Clin. J. Am. Soc. Nephrol.,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse renal outcomes following targeted therapies in renal cell carcinoma: a systematic review and meta-analysis;Frontiers in Pharmacology;2024-06-26

2. Risk Factors Analysis of AKI in Patients with Primary Non-small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitor;IRAN J KIDNEY DIS;2024

3. Immune checkpoint inhibitors and acute kidney injury;Frontiers in Immunology;2024-02-23

4. Incidence and risk factors of acute kidney injury in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis;Frontiers in Immunology;2023-05-29

5. Risk factors of immune checkpoint inhibitor-associated acute kidney injury: evidence from clinical studies and FDA pharmacovigilance database;BMC Nephrology;2023-04-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3